← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › TETRACYCLINES › Tetracyclines
penimepicycline
J01AA10
Forms & Strengths
- Capsules: 250mg, 500mg
- Tablets: 250mg, 500mg
- Oral suspension: 125mg/5mL, 250mg/5mL
Adult Dosing
- 500mg every 6 hours for 7-14 days for respiratory infections
- 250-500mg every 6 hours for 7-14 days for skin/skin structure infections
- 500mg every 6 hours for 14-28 days for urinary tract infections
Pediatric Dosing
- 25-50mg/kg/day divided every 6 hours for children over 8 years old
- Not recommended for children under 8 years old
Indications
- Respiratory tract infections
- Skin and skin structure infections
- Urinary tract infections
- Infections caused by susceptible gram-positive and gram-negative bacteria
Mechanism of Action
- Inhibits protein synthesis by binding to the 50S ribosomal subunit
- Bacteriostatic against susceptible bacteria
Contraindications
- Hypersensitivity to penicillins or cephalosporins
- Severe renal impairment
Adverse Reactions
- Nausea, vomiting, and diarrhea
- Allergic reactions, including anaphylaxis and rash
- Hepatotoxicity, including elevated liver enzymes
Drug Interactions
- Warfarin: increased INR and bleeding risk
- Methotrexate: decreased methotrexate clearance and increased toxicity
- Oral contraceptives: decreased contraceptive efficacy
Curated Content: Needs Vetting Before Put to Clinical Use